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Table 2. Results stratiﬁed by graft source, medial meniscus treatment, and car-
tilage status. Joint Space Difference (JSD) indicates (mJSW in the normal knee) –
(mJSW in the reconstructed knee)
Parameter JSD mean  SD P-value
Graft source
Bone-Patellar Tendon-Bone 0.38  0.55 mm P ¼ 0.13
Hamstrings 0.22  0.83 mm
Allograft 0.47  0.62 mm
Medial meniscus treatment
No tear 0.46  0.55 mm P < 0.001
Tear, no treatment 0.47  0.44 mm
Repair 0.18  0.75 mm
Partial meniscectomy 0.32  0.85 mm
Medial femoral condyle articular cartilage status
Normal / Grade I 0.35  0.65 mm P ¼ 0.086
Grade II-IV 0.11  0.76 mm
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S242at higher risk of developing post-traumatic OA. Patient reported out-
comes from the Multicenter Orthopaedic Outcomes Network (MOON)
prospective longitudinal cohort of over 1500 patients undergoing ACL
reconstruction showed no increase in OA symptoms (KOOS) at 2 or 6
years after surgery. Therefore, identiﬁcation of structural changes of OA
that may precede the onset of symptoms is of critical importance for
determining risk factors for the initiation and progression of post-
traumatic OA in addition to measuring the effectiveness of potential
disease-modifying treatments. One such structural measure of OA is
radiographic joint space width (JSW). The purpose of this study was
thus to examine whether JSW differences are evident in an onsite
cohort of patients 2 years after ACL reconstruction, and to determine
what factors predict more difference in JSW between ACL reconstructed
and contralateral normal knees.
Methods: 256 patients from the MOON cohort (111 males, 145 females,
mean age 20 years, range 12 - 33 at surgery) were recruited at a min-
imum of 2 years following surgery for on-site evaluations including
bilateral ﬁxed ﬂexion radiographs to assess JSW. (See table 1) To min-
imize bias related to pre-existing knee injury or OA, subjects were 35
years or younger, were injured playing a sport, had primary ACL
reconstructionwithout prior meniscus or articular cartilage surgery, did
not undergo subsequent ACL revision, and had a surgically normal
contralateral knee. Radiographic JSW was measured in the medial
compartment of both knees using a validated method to measure
minimum JSW (mJSW). The association of age, gender, BMI, meniscus
treatment, and articular cartilage treatment with mJSW differences
(JSD) between the reconstructed and normal knees was examined using
multivariable generalized linear models.
Results: The mean medial compartment mJSWwas 5.03  0.78 mm for
ACL reconstructed and 4.70  0.74 mm for contralateral normal knees
(p < 0.001). See Table 2 for stratiﬁed analyses of JSD by graft source,
medial meniscus treatment, and medial femoral condyle cartilage sta-
tus. A multivariable generalized linear model was constructed which
adjusted for age, gender, BMI, and baseline Marx activity level. Pre-
dictors of increased JSD that were statistically signiﬁcant included
increased age (p< 0.001), meniscus resection (p < 0.001) and meniscus
repair (p ¼ 0.003).
Conclusions: We found that radiographic mJSW differences between
reconstructed and normal knees could be detected 2 years after sur-
gery in a cohort of patients with previously uninjured knees who
sustained ACL tears and underwent subsequent ACL reconstruction.
JSD was greater in older patients and in knees that had partial medial
meniscectomy or repairs. There was no signiﬁcant difference based on
articular cartilage status. Interestingly, the overall average medial JSW
was increased in the reconstructed knees compared to the normal
knees, which may represent a swelling effect of articular cartilage in
the earliest stages of post-traumatic OA, and warrants further inves-
tigation.Table 1
Characteristics of the cohort
n 256
Males 111 (43.3%)
Age 20.1 year (SD 4.98)
BMI 23.6 (SD 3.67)
Graft source




No tear 152 (59.4%)
Tear, no treatment 28 (10.9%)
Repair 52 (20.3%)
Partial meniscectomy 24 (9.4%)
Medial femoral condyle articular cartilage status
Normal 230 (89.8%)
Grade I 3 (1.2%)
Grade II 19 (7.4%)
Grade III 1 (0.4%)
Grade IV 3 (1.2%)433
KNEE PAIN AND INFLAMMATION IN THE INFRAPATELLAR FAT PAD
ESTIMATED BY CONVENTIONAL AND DYNAMIC CONTRAST-
ENHANCED MAGNETIC RESONANCE IMAGING IN OBESE PATIENTS
WITH OSTEOARTHRITIS: A CROSS-SECTIONAL STUDY
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Purpose: To investigate the association between knee pain and signs of
inﬂammation in the infrapatellar fat pad (IPFP) in obese patients with
knee osteoarthritis (KOA).
Methods: In a cross-sectional setting, 3-Tesla conventional contrast-
enhanced (CE) magnetic resonance imaging (MRI) and dynamic con-
trast-enhanced (DCE)-MRI of KOA were analysed to quantify the extent
of inﬂammation in the IPFP and correlated to self-reported outcomes on
pain, symptoms and quality of life assessed via the Knee injury and
Osteoarthritis Outcome Score (KOOS). Data were from a weight-loss
maintenance study in obese KOA patients - the LIGHT study, including
patients50 years of age with a body mass index (BMI)30 kg/m2, and
clinical KOA veriﬁed on radiographs. Our study included all patients
attending the recall at the 1-year visit. The extent of inﬂammation in the
IPFP was assessed according to the MOAKS (MRI Osteoarthritis Knee
Score) recommendations using CE-MRI and by DCE-MRI perfusion
variables, analysed by use of the computer software program
Dynamika (Image analysis Ltd, London). A region of interest (ROI) was
drawn around the IPFP on the axial DCE-MR images from the apex of the
patella to the insertion of the patellar tendon on the tibia. For each voxel
within the ROI, signal intensity versus time curves were extracted and
automatically assigned to one of four patterns of contrast uptake: i) “no
enhancement”, ii) “persistent”, iii) “plateau” or iv) “washout”. “No
enhancement” and “persistent” are usually seen in disease-unaffected
tissues, whereas “plateau” is typical for tissues with higher perfusion,
and “washout” for blood vessels and severely inﬂamed tissues. From the
time intensity curves and contrast models, maximal enhancement
(ME), showing the intensity increase over the baseline of the curve, and
initial rate of enhancement (IRE), showing the increase in signal
intensity per second until maximum enhancement is reached, were
automatically calculated. The highest values for IRE andMEwere shown
in bright yellow and lower values in a spectrum towards red colours
(Fig.). The following perfusion variables were determined: S IRE x (N-
plateau þ N-washout) (“Inﬂammation”), S ME x (N-plateau þ N-
washout), N-plateau þ N-washout, volume of the IPFP, and “Inﬂam-
mation” divided by the volume of the IPFP. The perfusion variable
“Inﬂammation” was chosen as the primary perfusion variable in the
analysis. IRE is known to correlate with the grade of histological syno-
vial inﬂammation and N-plateau þ N-washout are the voxels with
pathological enhancement patterns. Intraclass correlation coefﬁcients
for the perfusion variables ranged from 0.81–0.99.
Baseline (BL) values and longitudinal changes from BL to 2-year follow-up (Y2)
in COMP and CILP
Mature athletes Adolescent athletes
Women Men Girls Boys
BL COMP 12.6  3.9 13.1  4.3 11.6  4.5 16.5  5.1
Change COMP 0.2  2.57 0.67  4.87 -0.85  6.17 0.03  3.75
BL CILP 1.72  1.11 1.16  1.05 0.59  0.48 0.62  0.57
Change CILP 0.70  1.79 1.64  1.97 2.41  1.25 0.70  0.95
ThCTnS (mm) 0.40  0.17 0.52  0.42 -0.10  0.10 0.22  0.20
ThCTkS (mm) 0.15  0.17 0.12  0.10 0.47  0.21 0.67  0.74
ThCChS (mm) 0.55  0.11 0.65  0.37 0.57  0.21 0.89  0.61
Fig. 1. Hoffa-synovitts (MOAKS grade 3). Arrows encapsulate the
enhancing lesions of various grades (AþB). A and B. Sagittal and axial knee
gradient echo (GRE) T1-weighted (T1w) VIBE post-contrast MRI. C. Axial
DCE-MRI GRE T1w VIBE sequence. Changes in signal intensity after
Gadolinium injection are shown for the region of interest (ROI), the
infrapatellar fat pad. Voxels are colour-coded for Initial rate of enhance-
ment (IRE).
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S243Results:MRI and clinical data were obtained in 95 patients. The typical
patient participating in this study was a 65-year old womanwith a body
mass index (BMI) of 32 kg/m2. The bivariate association between KOOS
pain and each of the DCE-MRI perfusion variables showed statistically
signiﬁcant correlations: S IRE x (N-plateau þ N-washout) (“Inﬂamma-
tion”) (r ¼ 0.42, p < 0.0001), S ME x (N-plateauþN-washout) (r ¼
-0.43, p < 0.0001), N-plateau þ N-washout (r ¼ 0.43, p < 0.0001),
volume of the IPFP (r ¼ -0.39, p ¼ 0.0001), and “Inﬂammation” divided
by the volume of the IPFP (r ¼ 0.37, p ¼ 0.0002). A statistically sig-
niﬁcant correlation was also seen between KOOS pain and MOAKS
Hoffa-synovitis (r ¼ 0.21, p ¼ 0.046).
Conclusions: Perfusion variables on DCE-MRI reﬂecting inﬂammation in
the IPFP and MOAKS Hoffa-synovitis were associated with knee pain in
obese KOA patients. These results suggest that severe inﬂammation in the
IPFP is associated with severe pain in KOA and that DCE-MRI is a robust
and promising method to study the impact of inﬂammation in KOA.
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SUBREGIONAL KNEE CARTILAGE THINNING OR THICKENING IS AGE-
DEPENDENT AND IS ASSOCIATED WITH SERUM BIOMARKERS IN
ADOLESCENT AND MATURE VOLLEYBALL ATHLETES
H. Boeth y, G.N. Duda y, A. Pramhed z, C. Klint z, J. Hed z, G. Diederichs x,
M. Hudelmaier k, S. Cotofana k, W. Wirth k, M. Hofmann-Amtenbrink{,
F. Eckstein k. y Julius Wolff Inst., Charite - Univ.smedizin Berlin, Berlin,
Germany; zAnaMar, Lund, Sweden; xDept. of Radiology, Charite -
Univ.smedizin Berlin, Berlin, Germany; k Inst. of Anatomy, Paracelsus
Med. Univ., Salzburg, Austria; {Mat Search Consulting Hofmann, Pully,
Switzerland
Purpose: Cartilage structural change caused by aging, training or dis-
ease can be accurately and directly measured using MRI; while bio-
marker quantiﬁcation from serum may be helpful in characterizing or
predicting cartilage maturation. Cartilage Oligomeric Matrix Protein
(COMP) represents an established serum biomarker of cartilage turn-
over, whereas Cartilage Intermediate Layer Protein (CILP) is a novel
biomarker that is thought to be associated with cartilage degradation.
In the current study we investigated whether MRI-based cartilage
thinning and thickening in young and mature athletes is related to
baseline or concurrent change in COMP and CILP levels
Methods: Twenty adolescent (baseline age 16.0  0.6 y) and 20 mature
(46.3  4.7 y) volleyball athletes were studied (10 men, 10 women). MR
images (3D VIBE) and serum markers were obtained at baseline (BL)
and at 2-year follow-up (Y2). Cartilage thickness was measured in 16
femorotibial subregions (8 medial, 8 lateral, 10 tibial, 6 femoral). Fem-
orotibial subregional cartilage thinning (ThCTnS) and thickening
(ThCTkS) scores were computed, by summarizing in each subject the BL
/ Y2 changes across all subregions with thinning and thickening,
respectively. Further, a cartilage change score (ThCChS) was computed
by summarizing the magnitudes of all subregional changes, inde-
pendent of direction. COMP was analyzed using the commercial sand-
wich COMP ELISA (AnaMar AB) and CILP with an in-house research
competitive immunoassay (AnaMar AB). Unpaired t-tests were used to
compare results between female andmale participants, paired t-tests to
test whether change from BL/ Y2 was signiﬁcant, and linear regres-
sion to analyze the correlation between serum and imaging markersResults: Data on COMP and MRI was available in 18 mature (9 men, 9
women) and 12 adolescent athletes (9 men, 3 women); data on CILP and
MRI was available in 15 mature (7 men, 8 women) and 8 adolescent
athletes (6men, 2women) (Table 1). Therewasno indication of signiﬁcant
differences (deﬁned by p  0.05) in serum or imaging markers between
menandwomen inmature (p>0.31)or adolescentathletes (p>0.17). The
mature athletes displayed much higher subregional cartilage thinning
than thickening scores, and the adolescent athletes much higher thick-
ening than thinning scores, whereas the non-directional change scores
were similar in mature and adolescent participants (Table 1). Pooled
analyses in both sexes suggested a signiﬁcant increase in CILP (p ¼ 0.02)
for BL/ Y2 in mature athletes, but no signiﬁcant change in COMP (p ¼
0.63). Similar relationships were observed in adolescent athletes (p ¼
0.009 for CILP, and 0.88 for COMP). In mature adults, BL / Y2 COMP
change was negatively correlated with BL COMP (r ¼ 0.62; p < 0.01, CI:
0.32,0.84), andBL/Y2CILP changewasnegativelycorrelatedwithBL
CILP (r¼ 0.73; p< 0.01, CI:0.53,0.87). Neither BL COMPand CILP, nor
BL/ Y2 COMP and CILP changes were signiﬁcantly correlated with each
other (p ¼ 0.06 and p ¼ 0.13, respectively). BL COMP and BL CILP levels
were not signiﬁcantly associated with subregional cartilage thinning,
thickening, or thenon-directional change score (p0.19). BL/Y2change
in COMPwas not signiﬁcantly associatedwith BL/Y2 change in imaging
markers. However, the association between BL/ Y2 change in CILP and
that in non-directional change score was signiﬁcant (r ¼ 0.48; p < 0.05).
Very similar observations were made in adolescent athletes (e.g.: r ¼
0.52; p ¼ 0.08 for BL/ Y2 CILP change vs. non-directional subregional
cartilage thickness change), but these associations did not reach statistical
signiﬁcance, given the much smaller sample size.
Conclusions: This study compares subregional MRI-based cartilage
thickness change, with baseline values and longitudinal change in two
serumbiomarkers (COMPand CILP). The above cartilage change scores are
particularly useful in correlation analyseswith serumbiomarkers, because
they describe structural tissue change in each direction (thinning and
thickening) at a subregional level. A limitation of this study is the small
sample size, in particular in the group of the adolescent athletes. Further,
the study was exploratory and did not correct for multiple statistical
testing. Nevertheless, our results indicate that longitudinal change in CILP
and COMP are negatively correlated to BL values, and that change in CILP
(but not change in COMP; nor BL CILP or COMP) is concurrently associated
with subregional cartilage change.435
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Purpose: Knee OA has a substantive impact on quality of life and its
early detection is essential for development of efﬁcient interventions.
Radiological MRI scores of cartilage damage have shown some pre-
dictive power in detecting which subjects may develop radiological OA
as deﬁned by KL scores. Further, T2 weighted imaging has been rou-
tinely used to detect cartilage lesions. The purpose of this study was to
1) evaluate whether the cartilage T2-relaxation-parameters are differ-
ent at the time of detection of radiological OA (ROA) in the incidence
